-
HHS unveils 3 new drug price models
HHS is taking aim at high prescription drug costs through three new programs announced Feb. 14. -
Pharmacists who prescribe found to be effective, safe in long-term care
Pharmacists allowed to prescribe medications to patients in long-term care facilities helped reduce drug burdens, according to a U.K. study published Feb. 14 in The BMJ. -
New York hospital swaps out 20-year-old script-filling robot
NYC Health + Hospitals' Elmhurst location dismantled its 20-year-old prescription-filling robot and replaced it with another that can fill 120 prescriptions each hour and carry 140 products, the site's pharmacy director, Peter Barber, PharmD, told Becker's. -
4 notes for clinicians on the newly revised immunization schedules
Immunization schedules have been revised for U.S. adults and children as of Feb. 10 for 2023 with new guidelines for COVID-19; measles, mumps and rubella; hepatitis B; and pneumococcal vaccination. -
1 in 10 recently approved drugs avoided their trial's goals: study
The FDA doesn't always approve drugs and medical devices that pass their trial goals, according to a study led by researchers from New Haven, Conn.-based Yale School of Medicine and Boston's Brigham and Women's Hospital. -
ASHP asks Biden for expanded pharmacists roles amid opioid epidemic
The American Society of Health-System Pharmacists' CEO sent President Joe Biden a letter Feb. 13 asking him to allow pharmacists to "finish the job" with lessening the nation's opioid use disorder epidemic. -
Baptist to break ground for 9-hospital central pharmacy in March
Louisville, Ky.-based Baptist Health partnered with pharmacy automation company Parata Systems to construct a mail-order and specialty pharmacy in Northern Kentucky "that will serve the entire nine-hospital system," according to a news release shared with Becker's. -
A look at 5 pharma bills backed by the ASHP
On Feb. 9, the Senate Judiciary Committee passed five bills supported by the American Society of Health-System Pharmacists that target pharmacy benefit managers and patent thickets. -
22 pharmacies to close in California after Walgreens deal
Pharmaca Integrative Pharmacies will close 22 storefronts in California after it was acquired by Walgreens, The U.S. Sun reported Feb. 11. -
Cuban's pharmacy may save US $1.2B annually with 9 drugs: Vanderbilt study
Mark Cuban Cost Plus Drug Co. has the potential to save some patients $1.29 billion a year, according to a study led by Vanderbilt University Medical Center researchers that evaluated 2020 Medicare Part D expenses for the nine most popular urological drugs. -
Where research stands on a fungal vaccine
HBO's popular zombie show The Last of Us is not the future for fungal infections, but thousands of Americans are hospitalized and hundreds die each year because of fungi, as there are no approved vaccines, NBC News reported Feb. 10. -
UN warns antibiotic resistance will rise as climate change persists
Growing resistance to antibiotics is nothing new, but the United Nations warned in a Feb. 7 press release that 10 million deaths could occur by 2050 if nothing is done to curb instances of drug resistance. -
CDC adds COVID-19 shots to routine vaccine schedules
The CDC's recommended immunization schedules for adults and children now include the COVID-19 vaccine. -
FDA warns pharmacies, healthcare staff to avoid drug with aluminum risk
The FDA warned healthcare workers and pharmacies on Feb. 9 not to use an unapproved potassium phosphates drug made by Hospira, a Pfizer company, in pediatric patients because the aluminum exposure can be up to double the agency's limit. -
Virginia hospital closes retail pharmacy
Children's Hospital of The King's Daughters in Norfolk, Va., abruptly closed the retail pharmacy it leased to Hague Pharmacy Feb. 8 because its lease expired, according to NBC affiliate WAVY. the hospital's in-house pharmacy is still open. -
CVS, others oppose rule aiming to keep mailed drugs at safe temperatures
The nation's first rule to ensure shipped medications are protected from heating up or cooling down too much is facing strong opposition, including CVS Health, healthcare organizations and trade groups, NBC News reported Feb. 8. -
A COVID-19 drug that works for all variants won't hit the market anytime soon — here's why
An experimental COVID-19 antiviral has been shown to cut the risk of hospital admission in half and appears to work across variants. Despite its promising attributes, it's unlikely to reach the U.S. market anytime soon because of regulatory challenges and a lack of funding, The New York Times reported Feb. 8. -
Pharmacy student's drug solution could save health systems $100K
Tyler Brisso, a pharmacy student and an employee at a Methodist Health System location, designed a drug compounding solution that has the potential to save the Omaha, Neb.-based system nearly $100,000 each year, NBC affiliate WOWT reported Feb. 8. -
10 systems seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
Following AbbVie's steps, Teva leaves PhRMA
About two months after AbbVie departed from the Pharmaceutical Research and Manufacturers of America, Teva Pharmaceuticals followed suit.
Page 50 of 50